This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity ...

Pfizer enters the lucrative weight-loss drug market with a massive $10 billion Metsera acquisition, targeting a $150-200 ...

This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentum—last week, the FDA added ...

WeightWatchers plans to offer Novo Nordisk's Wegovy as a pill in the U.S. next year, enhancing their partnership. This move ...

WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...

WW International ( WW ), popularly known as Weight Watchers, plans to sell Novo Nordisk's ( NVO) weight loss drug Wegovy in ...

End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss ...

Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve ...

WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, ...

Amid a major moment of grief for the Royal Family, an advertising campaign Sarah Ferguson had filmed was rapidly pulled from ...

new video loaded: Who Is Watching the Watchers? transcript The U.S. government doesn’t — and technically can’t — watch citizens every minute of every day. Palantir’s C.T.O. thinks the world would be ...

Dr. David Winter of Baylor Scott & White Health discusses how weight loss medications like Ozempic are impacting Americans. Trump's surgeon general nominee is a public health risk Trial underway in ...